Number of Shares
2,619.00
Current Holdings Value*
$51,960.00
% of Portfolio
1.61%
Total Estimate Gain
$2,264.12
% of Total Estimate Gain
4.69%

S&P SmallCap 600 Pure Growth Fund's ADMA Biologics Inc Holding Summary

As of 2025-03-31, RYDEX SERIES FUNDS held 2,619.00 shares of ADMA Biologics Inc(ADMA), totaling $51,960.00. This investment constitutes 1.61% of their stock portfolio, and RYDEX SERIES FUNDS now holds 0% of the outstanding ADMA Biologics Inc(ADMA) stock.

The initial trade took place in 2024Q3. And since then S&P SmallCap 600 Pure Growth Fund has made 2 purchases of ADMA, at an average price of $16.05, for a total of 3,009.00 shares. In addition, there have been 1 sales at an average price of $17.29 for 390.00 shares. Based on historical transaction data and ADMA's current price of $16.73, S&P SmallCap 600 Pure Growth Fund's estimated gain on his ADMA holdings is $2,264.12, reflecting a 4.69% gain to date.

S&P SmallCap 600 Pure Growth Fund ADMA ($16.73) Holding Chart

S&P SmallCap 600 Pure Growth Fund ADMA ($16.73) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1